Abstract
No public abstract is available from the verified source records.
Rodan Alqudah, Mohammed Saadeh, Daniel Khalil
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)
10.1001/archgenpsychiatry.2009.79 · 2009
Cotard’s syndrome: a review
10.1007/s11920-009-0031-z · 2009
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis
10.1016/s2215-0366(24)00006-3 · 2024
a double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features
10.1097/01.jcp.0000130557.08996.7a · 2004
Effect of older vs younger age on anthropometric and metabolic variables during treatment of psychotic depression with sertraline plus olanzapine: the STOP-PD II study
10.1016/j.jagp.2020.11.003 · 2021
Effect of continuing olanzapine vs placebo on relapse among patients with psychotic depression in remission: the STOP-PD II randomized clinical trial
10.1001/jama.2019.10517 · 2019
Metformin for the prevention of antipsychotic-induced weight gain: guideline development and consensus validation
10.1093/schbul/sbae205 · 2025
No additional external references are available.